Heart Failure With Preserved Ejection Fraction — EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
Citation(s)
The Safety and Efficacy of Empagliflozin in Patients With End-stage Renal Disease and Heart Failure With Preserved Ejection Fraction - a Randomized Controlled Trial